专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US11364279B2 Medicament used for treating hypertension 有权
公开(公告)号：US11364279B2
公开(公告)日：2022-06-21
申请号：US16073876
申请日：2017-01-20
申请人： Shandong Zhonghai Pharmaceutical CO. LTD
发明人： Long Cheng , Baozhen Xu , Qian Cheng
IPC分类号： A61K38/16 , A61K31/4025 , A61K35/62 , A61K36/02 , A61K36/03 , A61K36/04 , A61K36/05 , A61K36/25 , A61K36/284 , A61K31/7012 , A61P9/12 , A61K31/715
摘要： A medicament for use in treating hypertension. The medicament is a glycoprotein, a mixture of polysaccharide and protein, a polypeptide or a protein.

2. 发明授权

US10967032B2 Optimum ratio for herbs combination obtained by using scientific-based formula for hypertension treatment and a composition thereof 有权
公开(公告)号：US10967032B2
公开(公告)日：2021-04-06
申请号：US15992326
申请日：2018-05-30
申请人： Mun Fei Yam
发明人： Mun Fei Yam , Yean Chun Loh , Seng Hooi Loh
IPC分类号： A61K36/258 , A61K36/488 , A61K36/00 , A61K36/25 , A61K36/74 , A61K36/884 , A61P9/12
摘要： The present invention relates to a hypertension treatment. More particularly, the present invention relates to combination of four herbs' extract including 95% ethanolic extract of U. rhynchophylla (UR95), 95% ethanolic extract of P. thomsonii (PT95), 95% ethanolic extract of P. notoginseng (PN95), and 50% ethanolic extract of A. orientale (AO50) in particular range of ratio (known as F1 ratio), and all the raw herbs were then extracted in total by using 50% ethanol (known as F1-2) for use in a medicament for treating hypertension and hypertension-related complications and a composition thereof.

3. 发明授权

US10660924B2 Method for obtaining saponins from plants 有权
公开(公告)号：US10660924B2
公开(公告)日：2020-05-26
申请号：US15777891
申请日：2016-11-02
申请人： NATURAL RESPONSE, S.A.
发明人： Leandro Padilla Iglesias , Andres Valencia Michaud
IPC分类号： C07C13/62 , A61K36/185 , A61K36/73 , A61K36/25 , A61K36/896 , A61K36/48 , A61K36/77
摘要： The present application relates to a method for obtaining and purifying saponins from plant extracts, through a series of salting and filtrations steps, to provide high purity saponin extracts on large scale.

4. 发明申请

US20200093878A1 SYNERGISTIC HERBAL STIMULANT COMPOSITIONS 审中-公开
公开(公告)号：US20200093878A1
公开(公告)日：2020-03-26
申请号：US16142872
申请日：2018-09-26
申请人： Aretha Duncan
发明人： Aretha Duncan
IPC分类号： A61K36/296 , A61K36/41 , A61K36/25 , A61K36/185 , A61K36/81 , A61K36/31 , A61K36/88 , A61K36/48
摘要： A synergistic herbal stimulant composition comprises a mixture, in powdered or extract form, of two or more herbal stimulant ingredients and at least one catalytic herbal ingredient, which effects a synergy between the herbal stimulant ingredients. The herbal stimulant ingredients are preferably selected from the group consisting of Horny Goat Weed (Epimedium Sagittatum), Rhodiola Root (Rhodiola Rosea), Elueuthero Root (Eleutherococcus), Nettle Leaf (Urticaria Dioica), Ashwagandha Root (Withania Somnifera), Maca Root (Lepidium Meyenii), Moringa Root (Moringa Oleifera), and Cowitch (Macuna Pruriens). The catalytic herbal ingredient is preferably Moses-in-a-basket (Tradescantia Spathacea).

5. 发明申请

US20190038710A1 MEDICAMENT USED FOR TREATING HYPERTENSION 审中-公开
公开(公告)号：US20190038710A1
公开(公告)日：2019-02-07
申请号：US16073876
申请日：2017-01-20
申请人： Long CHENG
发明人： Long CHENG , Baozhen XU , Qian CHENG
IPC分类号： A61K38/16 , A61K31/715 , A61K31/7012 , A61K31/4025 , A61K36/05 , A61K36/04 , A61K36/02 , A61K36/03 , A61K36/25 , A61K35/62 , A61K36/284 , A61P9/12
摘要： A medicament for use in treating hypertension. The medicament is a glycoprotein, a mixture of polysaccharide and protein, a polypeptide or a protein.

6. 发明授权

US09301989B2 hTRPA1-activating composition and use thereof 有权
标题翻译： hTRPA1活化组合物及其用途
公开(公告)号：US09301989B2
公开(公告)日：2016-04-05
申请号：US14365582
申请日：2012-11-09
申请人： KOREA FOOD RESEARCH INSTITUTE
发明人： Mee Ra Rhyu , Hee Jin Son , Yi Seul Kim , Min Jung Kim , Hye Young Kim , Jae-Ho Park
IPC分类号： A01N65/00 , A61K36/8962 , A61K36/31 , A61K36/896 , A61K36/21 , A61K36/23 , A61K36/28 , A61K36/53 , A61K31/085 , A61K36/236 , A61K36/25 , A61K36/288 , A61K36/532 , A61K36/533 , G01N33/50
CPC分类号： A61K36/8962 , A61K31/085 , A61K36/21 , A61K36/23 , A61K36/236 , A61K36/25 , A61K36/28 , A61K36/288 , A61K36/31 , A61K36/53 , A61K36/532 , A61K36/533 , A61K36/896 , G01N33/5097 , G01N2500/04
摘要： A coniferyl alcohol or a Compositae family, Brassicaceae family, Umbelliferae family, Lamiaceae family, Liliaceae family or Amaranthaceae plant extract provides various uses associated with hTRPA1 activation, and, being a natural compound, involves relatively few side effects in the body and has substantial industrial applicability. The coniferyl alcohol or the Compositae family, Brassicaceae family, Umbelliferae family, Lamiaceae family, Liliaceae family or Amaranthaceae plant extract of the present invention not only will be a novel medical or food raw material which is helpful in maintaining homeostasis in the body associated with hTRPA1 activation, but can also be used to advantage in hTRPA1 antagonist screening.
摘要翻译：扁桃体醇或菊科，芸苔科，伞形科，紫菜科，百合科或苋科植物提取物提供与hTRPA1活化相关的各种用途，作为天然化合物，在体内涉及相对较少的副作用，适用性。本发明的针叶树醇或菊科，菊科，伞形科，蔷薇科，百合科或苋属植物提取物不仅是有助于维持与hTRPA1相关的体内的体内平衡的新型医药或食品原料激活，但也可用于hTRPA1拮抗剂筛选中的优势。

7. 发明申请

US20160015762A1 Antiviral supplement compositions and methods of use 审中-公开
标题翻译：抗病毒补充剂组合物和使用方法
公开(公告)号：US20160015762A1
公开(公告)日：2016-01-21
申请号：US14333645
申请日：2014-07-17
申请人： Jonathan Shelley Nimitz
发明人： Jonathan Shelley Nimitz
IPC分类号： A61K36/25 , A61K33/30 , A61K36/19 , A61K36/481 , A61K45/06 , A61K36/23 , A61K36/539 , A61K31/716 , A61K36/63 , A61K36/185 , A61K36/315
CPC分类号： A61K45/06 , A61K31/716 , A61K33/30 , A61K36/185 , A61K36/254 , A61K2300/00
摘要： The present invention relates to the field of dietary supplements, and in particular to antiviral compositions and methods of use. Compositions are described involving various combinations of Andrographis, Astragalus, Eleuthero, Isatis, Lomatium, Pelargonium, Sambucus, Scute, and/or Zinc, optionally with additional components. These combinations of supplements synergistically reduce both severity and duration of viral infections, including in particular colds and influenza, as well as providing additional benefits.
摘要翻译：本发明涉及膳食补充剂领域，特别涉及抗病毒组合物和使用方法。描述了包括穿心莲，黄芪，埃柳塞罗，茜素，茉莉，天竺葵，接骨木蛋白，Scute和/或锌的各种组合的组合物，任选地含有另外的组分。这些补充剂的组合协同地减少病毒感染的严重性和持续时间，特别是感冒和流感，以及提供额外的益处。

8. 发明申请

US20150273009A1 NEW FORMULATIONS COMPRISING PLANT EXTRACTS 审中-公开
标题翻译：包含植物提取物的新配方
公开(公告)号：US20150273009A1
公开(公告)日：2015-10-01
申请号：US14436351
申请日：2013-10-17
申请人： MONTERO GIDA SANAYI VE TICARET A.S.
发明人： Ümit Cifter , Nazife Arabacioglu , Özlem Toker
IPC分类号： A61K36/9068 , A61K36/185 , A61K45/06 , A61K36/25
CPC分类号： A61K36/9068 , A61K9/0095 , A61K35/644 , A61K36/185 , A61K36/25 , A61K36/28 , A61K36/484 , A61K45/06 , A61K47/10 , A61K2300/00
摘要： The present invention is related to a formulation comprising Hedera helix, Pelargonium sidoides, and Zingiber officinale extracts to be used in the treatment, prevention of various respiratory diseases or alleviation and/or elimination of symptoms thereof and a method for preparing said formulation.
摘要翻译：本发明涉及用于治疗，预防各种呼吸系统疾病或缓解和/或消除其症状的中草螺旋体，天竺葵苷和姜黄提取物的制剂及其制备方法。

9. 发明授权

US09119871B1 Method for treating cerebral edema or complication thereof 有权
标题翻译：治疗脑水肿或并发症的方法
公开(公告)号：US09119871B1
公开(公告)日：2015-09-01
申请号：US14281948
申请日：2014-05-20
申请人： Chen-Yu Lee
发明人： Chen-Yu Lee , Da-Tong Ju , Hsing-Lung Chao , Shih-Fang Chung , Hsin-I Ma , Yee-Min Jen
IPC分类号： A61K36/00 , A61K36/233 , A61K36/539 , A61K36/8888 , A61K36/25 , A61K36/8988 , A61K36/754 , A61K36/236 , A61K36/537 , A61K36/284 , A61K36/076 , A61K36/725 , A61K36/708 , A61K36/752 , A61K36/258 , A61K36/65
CPC分类号： A61K36/752 , A61K36/076 , A61K36/233 , A61K36/236 , A61K36/25 , A61K36/258 , A61K36/284 , A61K36/537 , A61K36/539 , A61K36/65 , A61K36/708 , A61K36/725 , A61K36/754 , A61K36/8888 , A61K36/8988 , A61K2300/00
摘要： A method for treating cerebral edema or complications thereof is disclosed. The method comprises administering a herbal medicinal composition to a subject in need, wherein the herbal medicinal composition comprises 1.3-5.3 parts by weight of Chaihu, 2.2-8.8 parts by weight of Hunagqing, 1.8-7.0 parts by weight of Panxia, 1.8-7.0 parts by weight of Chishaoyao, 0.5-1.8 parts by weight of Dahuang, 1.3-5.3 parts by weight of Zhishi, 2.2-8.8 parts by weight of Hungtsao, 4.4-17.5 parts by weight of Fuling, 1.8-7.0 parts by weight of Chuling, 2.2-8.8 parts by weight of Zerxie, 1.8-7.0 parts by weight of Changchu, 1.3-5.3 parts by weight of Mahuang, 1.8-7.0 parts by weight of Dansheng, 2.2-8.8 parts by weight of Chuanxiong, 2.2-8.8 parts by weight of Wuchuyu, 2.2-8.8 parts by weight of Tienma, 1.3-5.3 parts by weight of Ginseng, and 1.3-5.3 parts by weight of Chuanchi.
摘要翻译：公开了治疗脑水肿或其并发症的方法。该方法包括向需要的受试者施用草药组合物，其中所述草药组合物包含柴胡1.3-5.3重量份，Hun格青2.2-8.8重量份，潘夏1.8-7.0重量份，1.8-7.0重量份柴达奥重量份，大黄0.5-1.8重量份，志氏1.3-5.3重量份，红枣2.2-8.8重量份，F陵4.4-17.5重量份，ul陵1.8-7.0重量份，Zerxie 2.2-8.8重量份，Changchu 1.8-7.0重量份，Mahuang 1.3-5.3重量份，Dansheng 1.8-7.0重量份，Chuanxiong 2.2-8.8重量份，2.2-8.8重量份的武修玉，天津2.2-8.8重量份，人参1.3-5.3重量份，川崎1.3-5.3重量份。

10. 发明申请

US20150182571A1 COMPOSITION COMPRISING DENDROPANAX MORBIFERAEXTRACT OR COMPOUND DERIVED THEREFROM AS ACTIVE INGREDIENT FOR PREVENTING AND TREATING BENIGN PROSTATIC HYPERPLASIA 审中-公开
标题翻译：包含DENDROPANAX MORBIFERAEXTRACT或其衍生的化合物作为活性成分的组合物，用于预防和治疗BENIGN PROSTATIC HYPERPLASIA
公开(公告)号：US20150182571A1
公开(公告)日：2015-07-02
申请号：US14414883
申请日：2013-01-30
申请人： INDUSTRY-ACADEMIC COOPERATION FOUNDATION, CHOSUN UNIVERSITY
发明人： Cheol-Hee Choi , Young-Sook Moon , Ju-Hee Han , Kyoung-In Lee , Hyun-Jung Kim
IPC分类号： A61K36/25 , A23L1/30
CPC分类号： A61K36/25 , A23L33/105
摘要： Provided is a use of Dendropanax morbifera extract as an agent for preventing and treating benign prostatic hyperplasia, and more particularly, a composition for preventing and treating benign prostatic hyperplasia and a functional health food for preventing and reducing the effects of benign prostatic hyperplasia, in which the composition and food include, as an active ingredient, a Dendropanax morbifera extract or a compound which is isolated from the extract and then purified. The Dendropanax morbifera extract and the compound isolated from the extract have been demonstrated to be capable of effectively preventing and treating benign prostatic hyperplasia through a mechanism for inhibiting the androgen receptor signaling that induces benign prostatic hyperplasia. Therefore, the Dendropanax morbifera extract and the compound isolated from the extract according to the present invention can be effectively used in the production of medicines and functional foods capable of preventing, treating, and reducing the effects of benign prostatic hyperplasia and prostate cancer.
摘要翻译：提供了Dendropanax morbifera提取物作为预防和治疗良性前列腺增生的药剂的用途，更具体地，涉及用于预防和治疗良性前列腺增生的组合物和用于预防和减少良性前列腺增生的作用的功能性保健食品，其中组合物和食品包括作为活性成分的Dendropanax morbifera提取物或从提取物中分离然后纯化的化合物。已经证明了Dendropanax morbifera提取物和从提取物中分离的化合物能够通过抑制诱导良性前列腺增生的雄激素受体信号传导的机制来有效预防和治疗良性前列腺增生。因此，根据本发明的提取物中分离的落叶松提取物和化合物可以有效地用于生产能够预防，治疗和降低良性前列腺增生和前列腺癌的作用的药物和功能性食品。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式